Slatore Christopher G, Sullivan Donald R, Pappas Miranda, Humphrey Linda L
Health Services Research and Development, Portland, Oregon; Section of Pulmonary and Critical Care Medicine, Portland VA Medical Center, Portland, Oregon; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Portland, Oregon; Pacific Northwest Evidence-Based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Portland, Oregon.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Portland, Oregon.
J Thorac Oncol. 2014 Jul;9(7):927-934. doi: 10.1097/JTO.0000000000000210.
Lung cancer screening using low-dose computed tomography (LDCT) is now widely recommended for adults who are current or former heavy smokers. It is important to evaluate the impact of screening on patient-centered outcomes. Among current and former smokers eligible for lung cancer screening, we sought to determine the consequences of screening with LDCT, and subsequent results, on patient-centered outcomes such as quality of life, distress, and anxiety.
We searched the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the fourth Quarter 2012), MEDLINE (2000 to May 31, 2013), reference lists of articles, and Scopus for relevant English-language studies and systematic reviews. To evaluate the effect of LDCT screening on patient-centered outcomes, we included only randomized controlled trials (RCTs) involving asymptomatic adults. To evaluate the association of particular results and/or recommendations from a screening LDCT with patient-centered outcomes, we included results from RCTs as well as from cohort studies.
A total of 8215 abstracts were reviewed. Five publications from two European RCTs and one publication from a cohort study conducted in the United States met inclusion criteria. The process of LDCT lung cancer screening was associated with short-term psychologic discomfort in many people but did not affect distress, worry, or health-related quality of life. False-positive results were associated with short-term increases in distress that returned to levels that were similar to those among people with negative results. Negative results were associated with short-term decreases in distress.
As lung cancer screening is implemented in the general population, it will be important to evaluate its association with patient-centered outcomes. People considering lung cancer screening should be aware of the possibility of distress caused by false-positive results. Clinicians may want to consider tailoring communication strategies that can decrease the distress associated with these results.
对于现吸烟者或既往重度吸烟者,目前广泛推荐使用低剂量计算机断层扫描(LDCT)进行肺癌筛查。评估筛查对以患者为中心的结局的影响非常重要。在符合肺癌筛查条件的现吸烟者和既往吸烟者中,我们试图确定LDCT筛查及其后续结果对以患者为中心的结局(如生活质量、痛苦和焦虑)的影响。
我们检索了Cochrane对照试验中心注册库和Cochrane系统评价数据库(截至2012年第四季度)、MEDLINE(2000年至2013年5月31日)、文章参考文献列表以及Scopus,以查找相关的英文研究和系统评价。为了评估LDCT筛查对以患者为中心的结局的影响,我们仅纳入了涉及无症状成年人的随机对照试验(RCT)。为了评估LDCT筛查的特定结果和/或建议与以患者为中心的结局之间的关联,我们纳入了RCT以及队列研究的结果。
共审查了8215篇摘要。两项欧洲RCT的五篇出版物以及在美国进行的一项队列研究的一篇出版物符合纳入标准。LDCT肺癌筛查过程与许多人的短期心理不适相关,但不影响痛苦、担忧或与健康相关的生活质量。假阳性结果与痛苦的短期增加相关,随后恢复到与阴性结果者相似的水平。阴性结果与痛苦的短期降低相关。
随着肺癌筛查在普通人群中实施,评估其与以患者为中心的结局之间的关联将很重要。考虑进行肺癌筛查的人应意识到假阳性结果可能导致的痛苦。临床医生可能需要考虑调整沟通策略,以减少与这些结果相关的痛苦。